2-30736534-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_144575.3(CAPN13):c.1691C>T(p.Ala564Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000187 in 1,613,824 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144575.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAPN13 | NM_144575.3 | c.1691C>T | p.Ala564Val | missense_variant | 18/23 | ENST00000295055.12 | NP_653176.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAPN13 | ENST00000295055.12 | c.1691C>T | p.Ala564Val | missense_variant | 18/23 | 5 | NM_144575.3 | ENSP00000295055 | P1 | |
CAPN13 | ENST00000450650.5 | c.*1136C>T | 3_prime_UTR_variant, NMD_transcript_variant | 6/11 | 2 | ENSP00000403180 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152148Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000185 AC: 46AN: 249220Hom.: 0 AF XY: 0.000185 AC XY: 25AN XY: 135198
GnomAD4 exome AF: 0.000194 AC: 283AN: 1461676Hom.: 2 Cov.: 31 AF XY: 0.000177 AC XY: 129AN XY: 727118
GnomAD4 genome AF: 0.000118 AC: 18AN: 152148Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2023 | The c.1691C>T (p.A564V) alteration is located in exon 18 (coding exon 17) of the CAPN13 gene. This alteration results from a C to T substitution at nucleotide position 1691, causing the alanine (A) at amino acid position 564 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at